title: Some evidence that continuous subcutaneous insulin infusion for type I diabetes improves glycaemic control compared with multiple daily injections, but few trials have compared CSII with MDI using newer insulin analogues.
authors.affiliation: Diabetes and Endocrinology Center of Suffolk, 285 Sills Road, East Patchogue, NY 11772, USA. pwolffnp@optonline.net
authors.forename: Phyllis
authors.initials: P
authors.lastname: Wolff-McDonagh